Cargando…

Crystal Forms of the Antihypertensive Drug Irbesartan: A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis Investigation

[Image: see text] The design of new pharmaceutical solids with improved physical and chemical properties can be reached through in-detail knowledge of the noncovalent intermolecular interactions between the molecules in the context of crystal packing. Although crystallization from solutions is well-...

Descripción completa

Detalles Bibliográficos
Autores principales: Araya-Sibaja, Andrea Mariela, Fandaruff, Cinira, Guevara-Camargo, Ana María, Vargas-Huertas, Felipe, Zamora, William J., Vega-Baudrit, José Roberto, Guillén-Girón, Teodolito, Navarro-Hoyos, Mirtha, Paoli, Paola, Rossi, Patrizia, Jones, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089371/
https://www.ncbi.nlm.nih.gov/pubmed/35557697
http://dx.doi.org/10.1021/acsomega.2c00545
_version_ 1784704503046471680
author Araya-Sibaja, Andrea Mariela
Fandaruff, Cinira
Guevara-Camargo, Ana María
Vargas-Huertas, Felipe
Zamora, William J.
Vega-Baudrit, José Roberto
Guillén-Girón, Teodolito
Navarro-Hoyos, Mirtha
Paoli, Paola
Rossi, Patrizia
Jones, William
author_facet Araya-Sibaja, Andrea Mariela
Fandaruff, Cinira
Guevara-Camargo, Ana María
Vargas-Huertas, Felipe
Zamora, William J.
Vega-Baudrit, José Roberto
Guillén-Girón, Teodolito
Navarro-Hoyos, Mirtha
Paoli, Paola
Rossi, Patrizia
Jones, William
author_sort Araya-Sibaja, Andrea Mariela
collection PubMed
description [Image: see text] The design of new pharmaceutical solids with improved physical and chemical properties can be reached through in-detail knowledge of the noncovalent intermolecular interactions between the molecules in the context of crystal packing. Although crystallization from solutions is well-known for obtaining new solids, the effect of some variables on crystallization is not yet thoroughly understood. Among these variables, solvents are noteworthy. In this context, the present study aimed to investigate the effect of ethanol (EtOH), acetonitrile (MeCN), and acetone (ACTN) on obtaining irbesartan (IBS) crystal forms with 2,3-dibromosuccinic acid. Crystal structures were solved by single-crystal diffraction, and the intermolecular interactions were analyzed using the Hirshfeld surfaces analysis. The characterization of physicochemical properties was carried out by powder X-ray diffraction, Fourier transform infrared spectroscopy (FT-IR), thermal analysis, and solution-state NMR techniques. Two different IBS salts were obtained, one from MeCN and ACTN (compound 1) and a different one from EtOH (compound 2). The experimental results were in agreement with the findings obtained through quantum mechanics continuum solvation models. Compound 1 crystallized as a monoclinic system P2(1)/c, whereas compound 2 in a triclinic system P1̅. In both structures, a net of strong hydrogen bonds is present, and their existence was confirmed by the FT-IR results. In addition, the IBS cation acts as a H-bond donor through the N1 and N6 nitrogen atoms which interact with the bromide anion and the water molecule O1W in compound 1. Meanwhile, N1 and N6 nitrogen atoms interact with the oxygen atoms provided by two symmetry-related 2,3-dibromo succinate anions in compound 2. Solution-state NMR data agreed with the protonation of the imidazolone ring in the crystal structure of compound 1. Both salts presented a different thermal behavior not only in melting temperature but also in thermal stability.
format Online
Article
Text
id pubmed-9089371
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-90893712022-05-11 Crystal Forms of the Antihypertensive Drug Irbesartan: A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis Investigation Araya-Sibaja, Andrea Mariela Fandaruff, Cinira Guevara-Camargo, Ana María Vargas-Huertas, Felipe Zamora, William J. Vega-Baudrit, José Roberto Guillén-Girón, Teodolito Navarro-Hoyos, Mirtha Paoli, Paola Rossi, Patrizia Jones, William ACS Omega [Image: see text] The design of new pharmaceutical solids with improved physical and chemical properties can be reached through in-detail knowledge of the noncovalent intermolecular interactions between the molecules in the context of crystal packing. Although crystallization from solutions is well-known for obtaining new solids, the effect of some variables on crystallization is not yet thoroughly understood. Among these variables, solvents are noteworthy. In this context, the present study aimed to investigate the effect of ethanol (EtOH), acetonitrile (MeCN), and acetone (ACTN) on obtaining irbesartan (IBS) crystal forms with 2,3-dibromosuccinic acid. Crystal structures were solved by single-crystal diffraction, and the intermolecular interactions were analyzed using the Hirshfeld surfaces analysis. The characterization of physicochemical properties was carried out by powder X-ray diffraction, Fourier transform infrared spectroscopy (FT-IR), thermal analysis, and solution-state NMR techniques. Two different IBS salts were obtained, one from MeCN and ACTN (compound 1) and a different one from EtOH (compound 2). The experimental results were in agreement with the findings obtained through quantum mechanics continuum solvation models. Compound 1 crystallized as a monoclinic system P2(1)/c, whereas compound 2 in a triclinic system P1̅. In both structures, a net of strong hydrogen bonds is present, and their existence was confirmed by the FT-IR results. In addition, the IBS cation acts as a H-bond donor through the N1 and N6 nitrogen atoms which interact with the bromide anion and the water molecule O1W in compound 1. Meanwhile, N1 and N6 nitrogen atoms interact with the oxygen atoms provided by two symmetry-related 2,3-dibromo succinate anions in compound 2. Solution-state NMR data agreed with the protonation of the imidazolone ring in the crystal structure of compound 1. Both salts presented a different thermal behavior not only in melting temperature but also in thermal stability. American Chemical Society 2022-04-19 /pmc/articles/PMC9089371/ /pubmed/35557697 http://dx.doi.org/10.1021/acsomega.2c00545 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Araya-Sibaja, Andrea Mariela
Fandaruff, Cinira
Guevara-Camargo, Ana María
Vargas-Huertas, Felipe
Zamora, William J.
Vega-Baudrit, José Roberto
Guillén-Girón, Teodolito
Navarro-Hoyos, Mirtha
Paoli, Paola
Rossi, Patrizia
Jones, William
Crystal Forms of the Antihypertensive Drug Irbesartan: A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis Investigation
title Crystal Forms of the Antihypertensive Drug Irbesartan: A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis Investigation
title_full Crystal Forms of the Antihypertensive Drug Irbesartan: A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis Investigation
title_fullStr Crystal Forms of the Antihypertensive Drug Irbesartan: A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis Investigation
title_full_unstemmed Crystal Forms of the Antihypertensive Drug Irbesartan: A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis Investigation
title_short Crystal Forms of the Antihypertensive Drug Irbesartan: A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis Investigation
title_sort crystal forms of the antihypertensive drug irbesartan: a crystallographic, spectroscopic, and hirshfeld surface analysis investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089371/
https://www.ncbi.nlm.nih.gov/pubmed/35557697
http://dx.doi.org/10.1021/acsomega.2c00545
work_keys_str_mv AT arayasibajaandreamariela crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation
AT fandaruffcinira crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation
AT guevaracamargoanamaria crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation
AT vargashuertasfelipe crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation
AT zamorawilliamj crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation
AT vegabaudritjoseroberto crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation
AT guillengironteodolito crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation
AT navarrohoyosmirtha crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation
AT paolipaola crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation
AT rossipatrizia crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation
AT joneswilliam crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation